Caregiver perceptions in caring for post-stroke patients in Palopo City, South Sulawesi

Lolo, Lestari Lorna; Astrid, Maria

doi:10.1016/j.enfcli.2020.03.013

Search citation statements

Order By: Relevance

Paper Sections

Select...

Burden Of Disease1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stroke survivors find the disruptive result of their stroke affects their ability to maintain religious duties and contribute to their family [ 12 ]. Care givers experience heavy-heartedness, anger, disappointment, pity, sadness [ 13 ].…”

Section: Burden Of Diseasementioning

confidence: 99%

Stroke Burden and Stroke Services in Indonesia

Venketasubramanian

Yudiarto

Tugasworo

2022

Cerebrovasc Dis Extra

View full text Add to dashboard Cite

Stroke is a major cause of death and disability in Indonesia. Stroke requires high-quality, fast, and precise management to prevent and avoid disability and death. Stroke can be prevented by adequately controlling the risk factors and encouraging healthy lifestyles. Efforts are needed to organize health promotion programs at the community level. More and a better distribution of neurologists and neurointerventionalists is needed. All hospitals should have a CT scan machine and stroke units. Telemedicine for stroke patients is a very promising endeavor for an integrated acute stroke management system.

show abstract

Section: Burden Of Diseasementioning

confidence: 99%

Stroke Burden and Stroke Services in Indonesia

Venketasubramanian

Yudiarto

Tugasworo

2022

Cerebrovasc Dis Extra

View full text Add to dashboard Cite

show abstract

Lanadelumab in hereditary angioedema treatment

Sobotková¹

2022

Klin Farmakol Farm

View full text Add to dashboard Cite

Hereditární angioedém je vzácné onemocnění, jehož projevem jsou rekurentní angioedémy v různých lokalitách. Nejčastěji bývá podmíněn deficitem C1 inhibitoru. Za hlavní mediátor otoků považujeme u této diagnózy bradykinin. Lanadelumab je plně humánní monoklonální protilátka namířená proti plazmatickému kalikreinu, který z vysokomolekulárního kininogenu bradykinin vyštěpuje. Aktuálně je lanadelumab registrován pro dlouhodobou profylaktickou terapii hereditárního angioedému a představuje velmi účinnou a dobře tolerovanou léčebnou alternativu pro pacienty s častými a závažnými otoky.

show abstract

Caregiver perceptions in caring for post-stroke patients in Palopo City, South Sulawesi

Cited by 2 publications

References 3 publications

Stroke Burden and Stroke Services in Indonesia

Stroke Burden and Stroke Services in Indonesia

Lanadelumab in hereditary angioedema treatment

Contact Info

Product

Resources

About